ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,080Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 676

$647K Total Retail Price of All Prescriptions

Rank: 149 out of 676

498 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 12,423 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
OMEPRAZOLE 736 624 1 2
HYDROCODONE-ACETAMINOPHEN 603 430 S3 2 1
AMLODIPINE BESYLATE 511 465 3 3
METFORMIN HCL 504 404 4 8
SYNTHROID 493 416 5 48
LISINOPRIL 458 380 6 5
PRAVASTATIN SODIUM 422 320 7 11
SIMVASTATIN 348 255 8 6
FUROSEMIDE 338 295 9 4
MELOXICAM 319 262 10 13
HYDROCHLOROTHIAZIDE 312 270 11 12
METOPROLOL SUCCINATE 279 237 12 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 275 213 13 16
SERTRALINE HCL 256 218 14 26
ZOLPIDEM TARTRATE 239 218 15 21
GABAPENTIN 209 149 16 10
TRAMADOL HCL 206 164 17 19
LOVASTATIN 204 149 18 33
POTASSIUM CHLORIDE 198 168 19 9
ATORVASTATIN CALCIUM 195 168 20 20
ALLOPURINOL 180 151 21 31
CITALOPRAM HBR 179 141 22 17
CLONIDINE HCL 176 150 23 32
NEXIUM 155 140 24 23
ATENOLOL 154 154 25 25
METOPROLOL TARTRATE 142 129 26 22
BISOPROLOL-HYDROCHLOROTHIAZIDE 133 133 27 140
CRESTOR 126 120 28 29
LEVOTHYROXINE SODIUM 124 112 29 7
GLIMEPIRIDE 120 112 30 30
CARVEDILOL 116 109 31 15
LEVOXYL 113 88 32 186
KLOR-CON M20 107 107 33 67
CYMBALTA 106 71 34 47
PAROXETINE HCL 105 88 35 65
ROPINIROLE HCL 102 63 36 85
TAMSULOSIN HCL 101 96 37 38
NAPROXEN 101 76 37 71
ALENDRONATE SODIUM 98 78 39 61
COUMADIN 85 53 40 193
GEMFIBROZIL 83 62 41 137
ZETIA 81 48 42 89
CLOPIDOGREL 80 63 43 28
LYRICA 75 46 44 57
RANITIDINE HCL 74 55 45 27
BENAZEPRIL HCL 72 60 46 58
AMLODIPINE BESYLATE-BENAZEPRIL 70 64 47 44
AGGRENOX 69 69 48 147
AMITRIPTYLINE HCL 67 57 R 49 46
DIGOXIN 67 57 49 52
EVISTA 64 64 51 119
GLIPIZIDE ER 62 54 52 103
PREDNISONE 61 61 53 53
FLUOXETINE HCL 61 57 53 70
JANTOVEN 59 56 55 156
PLAVIX 58 42 56 40
CHLORTHALIDONE 57 47 57 164
ESCITALOPRAM OXALATE 56 55 58 73
MORPHINE SULFATE ER 54 35 S2 59 131
MECLIZINE HCL 52 40 60 83
TRAZODONE HCL 52 38 60 36
TRIAMTERENE-HCTZ 51 51 62 43
NAMENDA 50 49 63 35
DONEPEZIL HCL 50 50 63 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.